FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kidswell Bio's Free Cash Flow for the
six
months ended in Mar. 2026 was 円351 Mil. Kidswell Bio's Revenue for the
six
months ended in Mar. 2026 was 円3,314 Mil. Therefore, Kidswell Bio's FCF Margin % for the quarter that ended in Mar. 2026 was 10.60%.
The historical rank and industry rank for Kidswell Bio's FCF Margin % or its related term are showing as below:
TSE:4584'
s FCF Margin % Range Over the Past 10 Years
Min: -161.49 Med: -62.87 Max: 18.3
Current: -16.63
During the past 13 years, the highest FCF Margin % of Kidswell Bio was 18.30%. The lowest was -161.49%. And the median was -62.87%.
TSE:4584's FCF Margin % is ranked better than 64.67% of 951
companies
in the Biotechnology industry
Industry Median: -82.65
vs TSE:4584: -16.63
Kidswell Bio FCF Margin % Related Terms
Kidswell Bio FCF Margin % Historical Data
* Premium members only.
The historical data trend for Kidswell Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4584 vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Kidswell Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kidswell Bio FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kidswell Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kidswell Bio's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kidswell Bio (TSE:4584) has a FCF Margin % of 10.60% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kidswell Bio and its competitors. According to the industry distribution chart, Kidswell Bio ranks #336 out of 951 companies in the Biotechnology industry, placing it in the top 35.3%.
Is Kidswell Bio's FCF Margin % too high?
Kidswell Bio's current FCF Margin % is 10.60%. Based on the distribution chart, Kidswell Bio ranks #336 out of 951 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Kidswell Bio has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kidswell Bio ranks #336 out of 951 companies for FCF Margin %. This puts Kidswell Bio in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kidswell Bio and its competitors. Kidswell Bio's current FCF Margin % is 10.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円233.48, compared to a current price of 円156.00 — trading 33.2% below its estimated fair value. The current FCF Margin % is 10.60%. Kidswell Bio's overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current FCF Margin % is 10.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kidswell Bio (TSE:4584) Overvalued in 2026?
Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued.
The current stock price of 円156.00 is trading 33.2% below its estimated GF Value™ of 円233.48.
GuruFocus considers Kidswell Bio to be Possible Value Trap.
Key valuation signals for TSE:4584:
FCF Margin %: 10.60%
GF Value™: 円233.48 vs. price of 円156.00 (33.2% below fair value)
No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4584 has been successfully added to your 
